These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29879354)

  • 1. Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations.
    Evers A; Bossart M; Pfeiffer-Marek S; Elvert R; Schreuder H; Kurz M; Stengelin S; Lorenz M; Herling A; Konkar A; Lukasczyk U; Pfenninger A; Lorenz K; Haack T; Kadereit D; Wagner M
    J Med Chem; 2018 Jul; 61(13):5580-5593. PubMed ID: 29879354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists.
    Evers A; Haack T; Lorenz M; Bossart M; Elvert R; Henkel B; Stengelin S; Kurz M; Glien M; Dudda A; Lorenz K; Kadereit D; Wagner M
    J Med Chem; 2017 May; 60(10):4293-4303. PubMed ID: 28448133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.
    Chepurny OG; Matsoukas MT; Liapakis G; Leech CA; Milliken BT; Doyle RP; Holz GG
    J Biol Chem; 2019 Mar; 294(10):3514-3531. PubMed ID: 30622136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide.
    Chang R; Zhang X; Qiao A; Dai A; Belousoff MJ; Tan Q; Shao L; Zhong L; Lin G; Liang YL; Ma L; Han S; Yang D; Danev R; Wang MW; Wootten D; Wu B; Sexton PM
    J Biol Chem; 2020 Jul; 295(28):9313-9325. PubMed ID: 32371397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys.
    Elvert R; Bossart M; Herling AW; Weiss T; Zhang B; Kannt A; Wagner M; Haack T; Evers A; Dudda A; Keil S; Lorenz M; Lorenz K; Riz M; Hennerici W; Larsen PJ
    Endocrinology; 2018 Aug; 159(8):3105-3119. PubMed ID: 29992313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structure.
    Yang DH; Zhou CH; Liu Q; Wang MW
    Acta Pharmacol Sin; 2015 Sep; 36(9):1033-42. PubMed ID: 26279155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the GLP-1 receptor bound to a peptide agonist.
    Jazayeri A; Rappas M; Brown AJH; Kean J; Errey JC; Robertson NJ; Fiez-Vandal C; Andrews SP; Congreve M; Bortolato A; Mason JS; Baig AH; Teobald I; Doré AS; Weir M; Cooke RM; Marshall FH
    Nature; 2017 Jun; 546(7657):254-258. PubMed ID: 28562585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists.
    Jiang N; Jing L; Li Q; Su S; Yang Q; Zhou F; Chen X; Han J; Tang C; Tang W
    Eur J Med Chem; 2021 Feb; 212():113118. PubMed ID: 33422984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.
    Underwood CR; Garibay P; Knudsen LB; Hastrup S; Peters GH; Rudolph R; Reedtz-Runge S
    J Biol Chem; 2010 Jan; 285(1):723-30. PubMed ID: 19861722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Assembly of Exendin-4-Derived Dual Peptide Agonists is Mediated by Acylation and Correlated to the Length of Conjugated Fatty Acyl Chains.
    Wolff M; Schüler A; Gast K; Seckler R; Evers A; Pfeiffer-Marek S; Kurz M; Nagel N; Haack T; Wagner M; Thalhammer A
    Mol Pharm; 2020 Mar; 17(3):965-978. PubMed ID: 31968941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel thrombin-based triagonist with diabetes-protective and weight-lowering potential.
    Zhang J; Zhang Z; Ma C; Zeng L; Zhang Y; Wang P; Xu L
    Life Sci; 2020 Sep; 256():117853. PubMed ID: 32470452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptides-1 from phylogenetically ancient fish show potent anti-diabetic activities by acting as dual GLP1R and GCGR agonists.
    Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR
    Mol Cell Endocrinol; 2019 Jan; 480():54-64. PubMed ID: 30312651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling.
    Dods RL; Donnelly D
    Biosci Rep; 2015 Nov; 36(1):e00285. PubMed ID: 26598711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits weight-lowering and diabetes-protective effects.
    Zhou J; Cai X; Huang X; Dai Y; Sun L; Zhang B; Yang B; Lin H; Huang W; Qian H
    Eur J Med Chem; 2017 Sep; 138():1158-1169. PubMed ID: 28772236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule drug discovery at the glucagon-like peptide-1 receptor.
    Willard FS; Bueno AB; Sloop KW
    Exp Diabetes Res; 2012; 2012():709893. PubMed ID: 22611375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLP-1/glucagon receptor co-agonism for treatment of obesity.
    Sánchez-Garrido MA; Brandt SJ; Clemmensen C; Müller TD; DiMarchi RD; Tschöp MH
    Diabetologia; 2017 Oct; 60(10):1851-1861. PubMed ID: 28733905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics.
    Gómez Santiago C; Paci E; Donnelly D
    Biochem Biophys Res Commun; 2018 Mar; 498(2):359-365. PubMed ID: 29397068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule agonists for the glucagon-like peptide 1 receptor.
    Knudsen LB; Kiel D; Teng M; Behrens C; Bhumralkar D; Kodra JT; Holst JJ; Jeppesen CB; Johnson MD; de Jong JC; Jorgensen AS; Kercher T; Kostrowicki J; Madsen P; Olesen PH; Petersen JS; Poulsen F; Sidelmann UG; Sturis J; Truesdale L; May J; Lau J
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):937-42. PubMed ID: 17213325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane α-helix 2 and 7 are important for small molecule-mediated activation of the GLP-1 receptor.
    Rye Underwood C; Møller Knudsen S; Schjellerup Wulff B; Bräuner-Osborne H; Lau J; Knudsen LB; Peters GH; Reedtz-Runge S
    Pharmacology; 2011; 88(5-6):340-8. PubMed ID: 22134089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.